BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

Search

Fisher & Paykel Healthcare Corp Ltd

Затворен

СекторНедвижими имоти

32.26 1.96

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

30.4

Максимум

32.29

Ключови измерители

By Trading Economics

Приходи

153M

Продажби

951M

P/E

Средно за сектора

148.143

80.437

EPS

0.26

Дивидентна доходност

1.26

Марж на печалбата

16.106

Служители

6,978

EBITDA

276M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+20.89% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.26%

5.59%

Следващи печалби

28.05.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-3.8B

18B

Предишно отваряне

30.3

Предишно затваряне

32.26

Настроения в новините

By Acuity

61%

39%

166 / 192 Класиране в Real estate

Fisher & Paykel Healthcare Corp Ltd Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.02.2025 г., 21:55 ч. UTC

Пазарно говорене

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2.02.2025 г., 22:06 ч. UTC

Пазарно говорене

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28.11.2024 г., 21:55 ч. UTC

Пазарно говорене

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18.11.2024 г., 22:39 ч. UTC

Пазарно говорене

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2.09.2024 г., 23:56 ч. UTC

Пазарно говорене

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30.05.2024 г., 00:44 ч. UTC

Пазарно говорене
Печалби

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29.05.2024 г., 23:35 ч. UTC

Пазарно говорене

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28.05.2024 г., 22:43 ч. UTC

Пазарно говорене

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28.05.2024 г., 20:59 ч. UTC

Печалби

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28.05.2024 г., 20:58 ч. UTC

Печалби

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28.05.2024 г., 20:57 ч. UTC

Печалби

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28.05.2024 г., 20:56 ч. UTC

Печалби

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

24.04.2024 г., 02:38 ч. UTC

Пазарно говорене

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Fisher & Paykel Healthcare Corp Ltd Прогноза

Ценова цел

By TipRanks

20.89% нагоре

12-месечна прогноза

Среден 37.453 AUD  20.89%

Висок 42.7 AUD

Нисък 35 AUD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Fisher & Paykel Healthcare Corp Ltd през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

6 ratings

3

Купи

1

Задържане

2

Продай

Настроение

By Acuity

166 / 192 Класиране в Недвижими имоти

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.